A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.

Front Immunol · 2022 · PMC9393426 · PMID 36003381

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

According to the K-M analysis, the high-TMB group showed a trend toward better OS, PFS, and CSS than the low-TMB group ( Figures 3A–C ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.